Enhancement of bone formation in hydroxyapatite implants by rhBMP-2 coating

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 90, Issue 1, 2009, Pages 75-81

  Schnettler, Reinhard ^a   Knöß, Peter D ^a   Heiss, Christian ^a   Stahl, Jens Peter ^a   Meyer, Christof ^a   Kilian, Olaf ^a   Wenisch, Sabine ^a   Alt, Volker ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

BMP 2; Bone formation; Bone substitute; Histomorphometry; Hydroxyapatite

Indexed keywords

APATITE; BIOLOGICAL MATERIALS; BIOMATERIALS; COATINGS; CYLINDERS (SHAPES); DEFECTS; HYDROXYAPATITE; HYDROXYLATION; LABELS; MINING;

BMP-2; BONE DEFECT HEALING; BONE FORMATION; BONE INGROWTH; BONE SUBSTITUTE; CALCEIN; COATED IMPLANTS; CORTICAL BONE; FLUOROCHROME; GROWTH FACTOR; HA CERAMICS; HISTOMORPHOMETRY; HYDROXYAPATITE IMPLANTS; MULTI-TOPIC; OSTEOCONDUCTION; OSTEOCONDUCTIVE SCAFFOLDS; OSTEOINDUCTIVE EFFECTS; OSTEOINDUCTIVE PROPERTIES; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 (RHBMP-2); RHBMP-2; TETRACYCLIN; TIME-DEPENDENT;

BONE;

ALIZARIN; EDETATE DISODIUM; FLUOROCHROME; HYDROXYAPATITE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; TETRACYCLINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE CONDUCTION; BONE DEFECT; BONE GROWTH; COMPOSITE MATERIAL; CONTROLLED STUDY; CORTICAL BONE; HISTOLOGY; IMPLANT; MATERIAL COATING; MORPHOMETRICS; NONHUMAN; OSSIFICATION; TIBIA SHAFT;

ANIMALS; BONE DEVELOPMENT; BONE MORPHOGENETIC PROTEIN 2; DURAPATITE; FLUORESCENT DYES; PROSTHESES AND IMPLANTS; RECOMBINANT PROTEINS; SWINE; SWINE, MINIATURE;

EID: 67650825663     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31255     Document Type: Article

References (30)

1. Henkel KO, Dorfling P, Hartel J, Jonas L, Gundlach KK. Stimulating regeneration of bone defects by implantation of bioceramics and autologous osteoblast transplantation. Mund Kiefer Gesichtschir 2002;6:59-65.
2. Schnettler R, Alt V, Dingeldein E, Pfefferle HJ, Kilian O, Meyer C, Heiss C, Wenisch S. Bone ingrowth in bFGF-coated hydroxyapatite ceramic implants. Biomaterials 2003;24:4603-4608. (Pubitemid 37013621)
3. Alt V, Pfefferle HJ, Kreuter J, Stahl JP, Pavlidis T, Meyer C, Mockwitz J, Wenisch S, Schnettler R. Effect of glycerol-Llactide coating polymer on bone ingrowth of bFGF-coated hydroxyapatite implants. J Control Release 2004;99:103-111. (Pubitemid 39165737)
4. Urist MR. Bone formation by autoinduction. Science 1965; 150:893-899.
5. Urist MR, Mikulski A, Lietze A. Solubilized and insolubilized bone morphogenetic protein. Proc Natl Acad Sci USA 1979; 76:1828-1832. (Pubitemid 9207008)
6. Riley EH, Lane JM, Urist MR, Lyons KM, Liebermann JR. Bone Morphogenetic Protein-2: Biology and Applications. Clin Orthop Relat Res 1996;324:39-46.
7. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. Novel regulators of bone formation: Molecular clones and activities. Science 1988;242: 1528-1534. (Pubitemid 19023695)
8. Bax BE, Wozney JM, Ashhurst DE. Bone morphogenetic protein- 2 increases the rate of callus formation after fracture of the rabbit tibia. Calcif Tissue Int 1999;65:83-89.
9. Sandhu HS, Khan SN. Animal models for preclinical assessment of bone morphogenetic proteins in the spine. Spine 2002;27:32-38.
10. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, Aro H, Atar D, Bishay M, Borner MG, Chiron P, Choong P, Cinats J, Courtenay B, Feibel R, Geulette B, Gravel C, Haas N, Raschke M, Hammacher E, van der Velde D, Hardy P, Holt M, Josten C, Ketterl RL, Lindeque B, Lob G, Mathevon H, McCoy G, Marsh D, Miller R, Munting E, Oevre S, Nordsletten L, Patel A, Pohl A, Rennie W, Reynders P, Rommens PM, Rondia J, Rossouw WC, Daneel PJ, Ruff S, Ruter A, Santavirta S, Schildhauer TA, Gekle C, Schnettler R, Segal D, Seiler H, Snowdowne RB, Stapert J, Taglang G, Verdonk R, Vogels L, Weckbach A, Wentzensen A, Wisniewski T; BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002;84A:2123-2134.
11. Ono I, Ohura T, Murata M, Yamaguchi H, Ohnuma Y, Kuboki Y. A study on bone induction in hydroxyapatite combined with bone morphogenetic protein. Plast Reconstr Surg 1992;90:870-879.
12. Ripamonti U, Ma SS, Reddi AH. Induction of bone in composites of osteogenin and porous hydroxyapatite in baboons. Plast Reconstr Surg 1992;89:731-739.
13. Bauer HJ, Bauer M, Dingeldein E. Aufbau einer Hydroxylapatitkeramik biologischer Herkunft. Osteo Int 1994;2:106-110.
14. Dard M, Bauer J, Liebendörfer A, Wahlig H, Dingeldein E. Preparation, evaluations physico-chimiques et biologiques, d'une ceramique d'hydroxyapatite tissue de l'os de bovin. Act Odontostomatoln 1994;185:61-69.
15. Ruppert R, Hoffmann E, Sebald W. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur J Biochem 1996;237:295-302. (Pubitemid 26110301)
16. Donath K, Breuner G. A method for the study of undecalci- fied bones and teeth with attached soft tissues. The Sage- Schliff (sawing and grinding) technique. Oral Pathol 1982; 11:318-326.
17. Donath K. Die Trenn-D.unnschliff-Technik zur Herstellung histologischer Präparate von nicht schneidbaren Geweben und Materialien. Präparator 1988;34:197-206.
18. Burkus JK, Heim SE, Gornet MF, Zdeblick TA. Is INFUSE bone graft superior to autograft bone? An integrated analysis of clinical trials using the LT-CAGE lumbar tapered fusion device. J Spinal Disord Tech 2003;16:113-122. (Pubitemid 36397568)
19. Yasko AW, Lane JM, Fellinger EJ, Rosen V, Wozney JM, Wang EA. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. J Bone Joint Surg Am 1992;74:659-670.
20. Zegzula HD, Buck DC, Brekke J, Wozney JM, Hollinger JO. Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J Bone Joint Surg Am 1997; 79:1778-1790. (Pubitemid 28016582)
21. Chen X, Schmidt AH, Mahjouri S, Polly DW Jr, Lew WD. Union of a chronically infected internally stabilized segmental defect in the rat femur after debridement and application of rhBMP-2 and systemic antibiotic. J Orthop Trauma 2007;21: 693-700. (Pubitemid 350073453)
22. Schmidmaier G, Lucke M, Schwabe P, Raschke M, Haas NP, Wildemann B. Collective review: Bioactive implants coated with poly(D,L-lactide) and growth factors IGF-I, TGF-b1, or BMP-2 for stimulation of fracture healing. J Long Term Eff Med Implants 2006;16:61-69.
23. Kloss FR, Gassner R, Preiner J, Ebner A, Larsson K, Hächl O, Tuli T, Rasse M, Moser D, Laimer K, Nickel EA, Laschober G, Brunauer R, Klima G, Hinterdorfer P, Steinmüller-Nethl D, Lepperdinger G. The role of oxygen termination of nanocrystalline diamond on immobilisation of BMP-2 and subsequent bone formation. Biomaterials 2008; 29:2433-2442.
24. Willie BM, Bloebaum RD, Bireley WR, Bachus KN, Hofmann AA. Determining relevance of a weight-bearing ovine model for bone ingrowth assessment. J Biomed Mater Res A 2004;69:567-576.
25. Neuss S, Becher E, Woltje M, Tietze L, Jahnen-Dechent W. Functional expression of HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilisation, tissue repair and wound healing. Stem Cells 2004;22:405-414. (Pubitemid 38736624)
26. Amadeu TP, Coulomb B, Desmouliere A, Costa AM. Cutaneous wound healing: Myofibroblastic differentiation and in vitro models. Int J Low Extrem Wounds 2003;2: 60-68.
27. Miyazaki T, Kitagawa Y, Toriyama K, Kobori M, Torii S. Isolation of two human fibroblastic cell populations with multiple but distinct potential of mesenchymal differentiation by ceiling culture of mature fat cells from subcutaneous adipose tissue. Differentiation 2005;73:69-78. (Pubitemid 41583379)
28. Jabs A, Moncada GA, Nichols CE, Waller EK, Wilcox JN. Peripheral blood mononuclear cells acquire myofibroblast characteristics in granulation tissue. J Vasc Res 2005;42:174-180. (Pubitemid 41201983)
29. Postiglione L, Domenico GD, Montagnani S, Spigna GD, Salzano S, Castaldo C, Ramaglia L, Sbordone L, Rossi G. Granulocyte- macrophage colony-stimulating factor (GM-CSF) induces the osteoblastic differentiation of the human osteosarcoma cell line SaOS-2. Calcif Tissue Int 2003;72:85-97. (Pubitemid 36918942)
30. Modrowski D, Lomri A, Marie PJ. Endogenous GM-CSF is involved as an autocrine growth factor for human osteoblastic cells. J Cell Physiol 1997;170:35-46. (Pubitemid 27046521)